Publication Cover
Natural Product Research
Formerly Natural Product Letters
Volume 35, 2021 - Issue 18
297
Views
9
CrossRef citations to date
0
Altmetric
Short Communications

Anti-inflammatory effect and mechanism of action of ellagic acid-3,3′,4-trimethoxy-4′-O-α-L-rhamnopyranoside isolated from Hopea parviflora in lipopolysaccharide-stimulated RAW 264.7 macrophages

, , , , , , , , & show all
Pages 3156-3160 | Received 08 Jul 2019, Accepted 02 Nov 2019, Published online: 12 Nov 2019
 

Abstract

Phytochemical investigation of the stem bark of Hopea parviflora resulted in the isolation of 9 compounds; which includes friedelin (1), friedelin-3β-ol (2), (-)-ampelopsin A (3), (-)-ɛ-viniferin (4), (-)-hopeaphenol (5), vaticaphenol A (6), 2,4,8-trihydroxyphenanthrene-2-O-glucoside (7), ellagic acid-3,3’,4-trimethoxy-4’-O-α-L-rhamnopyranoside (8) and β-sitosterol-β-D-glucoside (9). Among them, compounds 1, 2, 6, 7, 8 and 9 are isolated for the first time from this species. Further, we evaluated the anti-inflammatory activity of compounds 4, 5, 6, 7 and 8. In this study, compound 8 inhibited the activity of proinflammatory mediators like NO, TNF-α, IL-6, 5-LOX and COX-2, also promoted the action of anti-inflammatory mediator like IL-10 via inhibition of the NF-κB pathway in LPS-stimulated RAW 264.7 macrophages.

Graphical Abstract

Acknowledgements

B. P, T. S. P, P. S and G. G. thank CSIR and UGC for research fellowships. S.S thank SERB-DST for post-doctoral fellowship.

Disclosure statement

The authors confirm that this article content has no conflict of interest.

Additional information

Funding

This work was supported by the Department of Science and Technology (DST), New Delhi (Grant number SR/S1/OC-24/2014).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.